Breast cancer chemotherapy can cause side effects due to nonspecific drug delivery, low solubility and fast metabolism of drugs used in conventional therapy. Moreover, the therapeutic effect of the 
Introduction
Breast cancer is the most common neoplasm, among all cancer types affecting females. It represents 25% of all cancer cases and the leading cause of cancer mortality (15%). The number of those who die of this neoplasm remains high, even if in the last years screening, early diagnosis and improved therapeutic protocols contributed to a fall in total cancer mortality, with a favourable trend also for breast cancer [1] .
Conventional chemotherapy for breast cancer can cause severe side effects due to distribution to off-target tissues [2, 3] . Moreover, the therapeutic potential of these drugs is often reduced by the onset of chemoresistance that occurs in a variety of distinct mechanisms and pathways. These include a reduction of intracellular pro-drug activation and an increased drug inactivation by Phase I and/or II enzymes [4] .
In order to overcome the critical aspects of conventional chemotherapy, new nanotechnology-based approaches are currently under investigation. In particular, different types of nanocarriers, including polymeric nanoparticles, liposomes, micelles and magnetic nanoparticles were experimentally tested for cancer diagnosis, imaging and treatment [5] . In particular, superparamagnetic iron oxide nanoparticles (SPIONs) have been proposed for diagnostic assays, for local hyperthermia-based cancer therapy and intra-tumour delivery of conventional drugs or monoclonal antibodies, viral vectors engineered with genes or shRNAs [6] [7] [8] . Due to the chance of targeting tumor with SPIONs, their side effects on non-cancerous tissues can be reduced [9] .
Physico-chemical and biological properties of SPIONs can be improved through surface modifications, increasing also the nanoparticle dispersion [10, 11] . Our previous study highlighted that SPIONs functionalized with CLA, known for its anticancer properties, have an increased dispersion and a stronger cytotoxic effect on mouse breast cancer cells 4T1 in comparison with SPIONs alone [12] .
In the present study, the mechanisms underlying the effect of CLA-functionalized SPIONs (SPIONs+CLA) were investigated. Particular attention was paid to the type of cell death induced, to the effect on inflammation process, to the possible involvement of PPARs and to the effect on P-gp and ALDH3A1 which are involved in cancer chemoresistance. PPARs were investigated because CLA is a natural ligand of these nuclear hormone receptors that regulate the expression of genes involved in several intracellular signal transduction pathways, including proliferation and survival.
Materials and Methods

Materials
Unless otherwise specified reagents were purchased from Sigma-Aldrich, Germany
SPION preparation
Synthesis and characterization of SPIONs were carried out as previously described [12] . In the experiments reported here SPIONs alone and SPIONs coated with a single layer of CLA, at the highest of the two amounts that were initially synthetized (4.5 µl CLA/ml of SPION suspension, SPIONs+CLA), were used for cell treatment.
Cell Cultures and Treatment of cells with SPIONs
Mouse breast cancer cells 4T1 were seeded (12, 
Cell growth and viability
At the different experimental times (12, 24, 48 A549 and A427 cells were detached by trypsin/EDTA (0.5%/0.03 mM) at 72 h and used for growth evaluation only.
Inhibition of PPAR by antagonist GW9662
Mouse breast cancer cells 4T1 treated as reported in section 2.3 were also supplemented with 10 μM GW9662, a well known PPAR antagonist. In these experiments the following groups were 
Western Blot and Real-time PCR analyses
Proteins and total RNA were isolated from 4T1 cells using the Tri-Reagent Kit according to the manufacturer's protocol.
35 µg of proteins were separated by SDS-polyacrylamide gel electrophoresis and electrotransferred to a polyvinylidene difluoride (PVDF) membrane (Thermo Fisher Scientific, MA), which was then blocked for 1 hour with TBS containing 5% non-fat dry milk. The membrane was then rinsed and incubated overnight with polyclonal anti-PPARα or anti-PPARγ antibodies (SantaCruz Biotechnology Inc., CA) and monoclonal anti-β-actin antibodies. Protein bands were visualized using a chemiluminescent detection system (Pierce® ECL Plus Western Blotting Substrate, Thermo Scientific, IL) 1 μg of total RNA was reverse transcribed to cDNA using the High-Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, CA). 16 l of a PCR mixture containing 2 μl of cDNA template, 5 pmoles each of forward and reverse primers ( 
Protein content determination
Protein content was measured using the DC TM Protein Assay Kit, following the manufacturer's instructions (Bio-Rad Laboratories Inc., CA).
Pro-inflammatory cytokine protein content
TNFα and IL-1 content was evaluated in the culture medium by Enzyme Linked Immuno Sorbent Assay (Invitrogen Corporation, Frederick, MD).
Statistical Analysis
All data were expressed as means ± SD. Differences between group means were assessed by analysis of variance followed by the post hoc Newman-Keuls test.
Results
Mouse breast cancer 4T1 cells were exposed to 8, 16 or 32 µg/10 5 cells of SPIONs or
SPIONs+CLA and the variations in cell number were recorded for up to 72 hours as reported in The flow cytometry analysis of viability and of type of cell death is reported in Figure 2 .
The results evidenced that both treatments induced necrosis and a few apoptosis, but the cytotoxic effect induced by SPIONs+CLA was bigger. Since CLA is a ligand of PPARs, as other polyunsaturated fatty acids, PPARγ protein content was evaluated. Figure 3 shows an increase of PPARγ at 24 h in cells treated with both SPIONs in comparison with the control cells, the increase being bigger in cells treated with
SPIONs+CLA and consistent with the reduction of cell number and cell toxicity.
The involvement of PPAR in reducing 4T1 cell growth has been investigated using GW9662, a well known antagonist of this nuclear receptor. Results reported in Table 3 evidenced that the inhibition of PPAR by GW9662 always increased the cell numbers, being the major recovery present in case of SPIONs + CLA.
The presence of cell necrosis suggested to evaluate some inflammation-related parameters:
PPARα, TNFα and IL-1β at the experimental time of 72 h. P-gp and ALDH3A1 were evaluated in order to investigate the effect of these types of SPIONs on the mechanism involved in cancer chemoresistance. Figure 5 shows a decrease of P-gp and ALDH3A1 in 4T1 cells treated with both types of SPIONs, being SPIONs+CLA the most efficient in the decrease.
Discussion
In a previous study we evidenced that SPIONs functionalized with CLA affected viability of 4T1 breast cancer cells, being the effect observed bigger if compared to SPIONs alone. This effect is due to the increased colloidal stability and the anti-cancer properties of the CLA [13] .
In this study we investigated the molecular pathways triggered by SPIONs+CLA, paying particular attention to the effect on cell proliferation and cell death. Moreover, to confirm the ability The acquired resistance to drugs (MDR) could be due to copy number alterations or increased expression of different genes [16] and is an important impediment for successful chemotherapy [18, 19] . The most important and well-studied MDR-genes are: ABCB 1 that encodes the P-glycoprotein (P-gp), the multidrug resistance protein 1 (MDR1), ABCC 1-3 that encodes the multi-drug resistance associated protein (MRP) 1-3 and ABCG 2 encoding the breast cancer resistance protein (BCRP). Different strategies were developed to reduce MDR-associated gene expressions including the use of surfactants that inhibit the drug-efflux and polymers for their ability to improve the intracellular transport of chemotherapeutics [16] . Recently, different studies have evaluated the capability of various nanoparticle formulation in overcoming MDR in breast cancer, showing that drugs encapsulated by nanomaterials enter the cancer cells through different mechanisms overcoming the drug transporters and reversing MDR [17] .
P-gp was one of the first efflux transporter discovered [20] [21] [22] ; it provides, in physiological conditions, protection from xenobiotics during brain development and it was highlighted to be upregulated by glucocorticoids and inhibited by pro-inflammatory cytokines [22] . In different "in vivo" and "in vitro" liver and colon tumor models TNFα downregulated ABCB 1 expression, causing a reduction of drug efflux and an increase of cytotoxicity [23, 24] . This correlation was confirmed also in this study where the functionalization with CLA increased the production of TNFα and IL-1β and decreased the expression of P-gp in comparison with control cells and cells treated with SPIONs alone.
The ability of cancer cells to block the effect of drugs is also due to the increased expression of ALDH3A1. SPIONs + CLA reduced the expression of ALDH3A1 through the increase of PPARγ.
This inverse correlation between ALDH3A1 and PPARγ was shown in our previous study on human lung tumor A549 cells where the ALDH3A1 expression was decreased by arachidonic acid, another ligand of PPARs, via the activation of PPARγ and the consequent inhibition of NF-κB transcriptional activity. In fact, ALDH3A1 gene possesses several NF-κB binding sites [25, 26] which are involved in the positive and negative regulation of its expression [27] .
Conclusions
This research demonstrated the SPIONs functionalized with CLA are able to reduce cell number, induce necrotic cell death and inflammation in mouse breast 4T1 cells. These effects are mediated by PPARs: the increase of PPARγ correlated with the decreased cell proliferation and the decrease of PPARα with the increase of pro-inflammatory cytokines. In turn, this increase is responsible for the decrease of P-gp mRNA level. The increase of PPARγ also correlates with the decrease of ALDH3A1.
The study results indicate that the anti-cancer properties of SPIONs functionalized with CLA are mediated by PPARs, being changes in these nuclear receptors correlated with induction of cytotoxicity and inflammation, and decreased ability of cancer cells in blocking anticancer drug effect.
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